Agios Pharmaceuticals (NASDAQ: AGIO) announced results from its Phase 3 RISE UP trial of mitapivat in sickle ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE